ASGN vs GSK · P/E 14, rev $4.10B vs P/E 13, $103.31B cap
ASGN Inc (ASGN) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
ASGN Inc (ASGN) is a information technology services company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ASGN revenue for 2024-12-31 was $4.10B. Net income was $175.2M. Revenue was down 7.9% from 2023-12-31 to 2024-12-31. ASGN currently screens at market cap $2.20B and trailing P/E 14.3.
GSK does not have a complete income-statement cache yet.
ASGN currently screens at market cap $2.20B and trailing P/E 14.3. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ASGN and GSK stock pages for the full models.
Not investment advice.